Accessibility Tools
Hide
Dr. Prabhat Sinha, Internal Medicine and Geriatric Physician, Bayville, Toms River // Media // Healthcare News » Zepbound bests Wegovy for weight loss in new trial
Posted on: 19-Jan-2025

Source: Medical Xpress

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.

Read More

  • Community Medical Centers
  • Walden University
  • AMA
  • American Board of Internal Medicine

Locations & Directions